LABORATORIOS FARMACEUTICOS ROVI, S.A. «12345...» Page 3 out of 19 23/04/2024 11:07 LABORATORIOS FARMACEUTICOS ROVI, S.A. Board of Directors Regulations La sociedad remite el reglamento del Consejo de Administración Register number: 28144 19/04/2024 10:03 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 12 April 2024 and 18 April 2024 Register number: 28099 12/04/2024 10:45 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 5 April 2024 and 11 April 2024 Register number: 28001 05/04/2024 10:39 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 28 March 2024 and 4 April 2024 Register number: 27861 02/04/2024 07:03 LABORATORIOS FARMACEUTICOS ROVI, S.A. Other relevant information The Company releases the press release related to the FDA’s approval of Risvan® (Risperidone ISM®) as a treatment for schizophrenia Register number: 27772 29/03/2024 09:32 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 22 March 2024 and 27 March 2024 Register number: 27758 22/03/2024 10:21 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 15 March 2024 and 21 March 2024 Register number: 27637 15/03/2024 10:17 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 8 March 2024 and 14 March 2024 Register number: 27476 12/03/2024 13:50 LABORATORIOS FARMACEUTICOS ROVI, S.A. Other relevant information ROVI informs of the agreement that has been concluded with Insud Pharma and Innvierte (CDTI) to incorporate, together with these two entities, a limited company engaged in the research and development of advanced therapies. Register number: 27397 08/03/2024 09:30 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 1 March 2024 y and 7 March 2024 Register number: 27325 Page 3 out of 19 «12345...»
